Clinical Trial Update: Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions. [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study comparing a single-dose 180 mg bempedoic acid film-coated tablet to Nilemdo 180 mg film-coated tablets was completed in healthy, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• Bempedoic Acid (bempedoic acid)
• Nilemdo (bempedoic acid)

Snippet

Sponsor: Humanis Saglık Anonim Sirketi | Conditions: Hypercholesterolaemia, Mixed Dyslipidaemia | Phase 1 | Status: COMPLETED